| Date | Detail |
|---|---|
| Dec 03, 2018 |
BeiGene Analyst and Investor Event
|
| Nov 28, 2018 |
BeiGene, Ltd. at the 30th Annual Piper Jaffray Healthcare Conference
|
| Oct 12, 2018 |
IWWM Oral Presentation on Zanubrutinib
|
| Oct 03, 2018 |
BeiGene, Ltd. at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
|
| Oct 02, 2018 |
BeiGene, Ltd. at the Ladenburg Thalmann 2018 Healthcare Conference
|
| Sep 12, 2018 |
BeiGene, Ltd. at the Morgan Stanley 16th Annual Global Healthcare Conference
|
| Jun 15, 2018 |
BeiGene, Ltd. at the 23rd Congress of the European Hematology Association (EHA)
|
| Jun 12, 2018 |
BeiGene, Ltd. at the William Blair 2018 Growth Stock Conference
|
| Jun 12, 2018 |
BeiGene, Ltd. at the Goldman Sachs 39th Annual Global Healthcare Conference
|
| May 23, 2018 |
BeiGene, Ltd. at the UBS Global Healthcare Conference
|
| May 08, 2018 |
BeiGene, Ltd. at the Deutsche Bank 43rd Annual Health Care Conference
|
| Mar 14, 2018 |
BeiGene, Ltd. at The Barclays Global Healthcare Conference 2018
|
| Mar 12, 2018 |
BeiGene, Ltd. at The Cowen and Company 38th Annual Health Care Conference
|
| Feb 14, 2018 |
BeiGene at LEERINK Partners 7th Annual Global Healthcare Conference
|
| Jan 07, 2018 |
Investor 1x1 Meetings at J.P. Morgan Conference
|
| Dec 09, 2017 |
ASH Data Review
|
| Sep 12, 2017 |
BeiGene, Ltd. at Morgan Stanley 15th Annual Global Healthcare Conference
|
| Sep 06, 2017 |
BeiGene, Ltd. at Baird’s 2017 Global Healthcare Conference
|
| Jul 06, 2017 |
Investor Call to Discuss Global Strategic Collaboration with Celgene
|
| Jun 16, 2017 |
Analyst Call to Discuss BGB-3111 Updates at 14-ICML
|
